1. Home
  2. GDTC vs CENN Comparison

GDTC vs CENN Comparison

Compare GDTC & CENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • CENN
  • Stock Information
  • Founded
  • GDTC 2018
  • CENN 2013
  • Country
  • GDTC Singapore
  • CENN United States
  • Employees
  • GDTC N/A
  • CENN N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • CENN Auto Manufacturing
  • Sector
  • GDTC Health Care
  • CENN Consumer Discretionary
  • Exchange
  • GDTC Nasdaq
  • CENN Nasdaq
  • Market Cap
  • GDTC 28.0M
  • CENN 23.1M
  • IPO Year
  • GDTC 2023
  • CENN N/A
  • Fundamental
  • Price
  • GDTC $2.35
  • CENN $1.01
  • Analyst Decision
  • GDTC Buy
  • CENN
  • Analyst Count
  • GDTC 1
  • CENN 0
  • Target Price
  • GDTC $5.00
  • CENN N/A
  • AVG Volume (30 Days)
  • GDTC 9.6K
  • CENN 110.9K
  • Earning Date
  • GDTC 01-01-0001
  • CENN 05-19-2025
  • Dividend Yield
  • GDTC N/A
  • CENN N/A
  • EPS Growth
  • GDTC N/A
  • CENN N/A
  • EPS
  • GDTC N/A
  • CENN N/A
  • Revenue
  • GDTC $368,838.00
  • CENN $31,297,393.00
  • Revenue This Year
  • GDTC $5.37
  • CENN N/A
  • Revenue Next Year
  • GDTC N/A
  • CENN N/A
  • P/E Ratio
  • GDTC N/A
  • CENN N/A
  • Revenue Growth
  • GDTC N/A
  • CENN 200.20
  • 52 Week Low
  • GDTC $1.20
  • CENN $0.64
  • 52 Week High
  • GDTC $4.05
  • CENN $2.30
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 49.94
  • CENN 70.57
  • Support Level
  • GDTC $2.26
  • CENN $0.78
  • Resistance Level
  • GDTC $2.60
  • CENN $0.90
  • Average True Range (ATR)
  • GDTC 0.13
  • CENN 0.06
  • MACD
  • GDTC 0.00
  • CENN 0.02
  • Stochastic Oscillator
  • GDTC 40.38
  • CENN 71.86

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About CENN Cenntro Electric Group Limited

Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles powered by either electricity or hydrogen energy sources. The company's commercial vehicles are designed to serve a variety of fleet and municipal organizations in support of city services, last-mile delivery, and other commercial applications. It has developed a series of commercial vehicle models, including Metro, Logistar, Logimax, Avantier, Teemak, and Antric One. In addition, the company has introduced an open-platform, programmable all-electric iChassis platform, designed for automated and autonomous driving. Geographically, the company generates maximum revenue from vehicle sales in the United States, and also has a presence in Europe, Asia, and other regions.

Share on Social Networks: